Free Trial
→ Read now. Do not delete. You’ve been warned. (From Porter & Company) (Ad)tc pixel Free RXO Stock Alerts

RXO (RXO) Financials

RXO logo
$28.48 +0.13 (+0.46%)
Closing price 06/12/2026 03:59 PM Eastern
Extended Trading
$28.36 -0.12 (-0.42%)
As of 06/12/2026 06:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for RXO

Annual Income Statements for RXO

This table shows RXO's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 43 150 92 4.00 -290 -100
Consolidated Net Income / (Loss)		 43 150 92 4.00 -290 -100
Net Income / (Loss) Continuing Operations		 43 150 92 4.00 -290 -100
Total Pre-Tax Income 		57 191 119 4.00 -304 -115
Total Operating Income		 60 192 123 39 -56 -79
Total Gross Profit		 789 1,008 1,172 960 985 1,131
Total Revenue		 3,357 4,689 4,796 3,927 4,550 5,742
Operating Revenue		 3,357 4,689 4,796 3,927 4,550 5,742
Total Cost of Revenue		 2,568 3,681 3,624 2,967 3,565 4,611
Operating Cost of Revenue		 2,568 3,681 3,624 2,967 3,565 4,611
Total Operating Expenses		 729 816 1,049 921 1,041 1,210
Selling, General & Admin Expense		 455 539 640 591 666 832
Depreciation Expense		 76 81 86 67 87 116
Other Operating Expenses / (Income)		 174 192 226 235 202 190
Impairment Charge		 - - - 0.00 0.00 12
Restructuring Charge		 24 4.00 97 28 86 60
Total Other Income / (Expense), net		 -3.00 -1.00 -4.00 -35 -248 -36
Interest & Investment Income		 0.00 0.00 -4.00 -32 -30 -35
Other Income / (Expense), net		 -3.00 -1.00 0.00 -3.00 -218 -1.00
Income Tax Expense		 14 41 27 0.00 -14 -15
Basic Earnings per Share		 $0.37 $1.30 $0.80 $0.03 ($2.17) ($0.59)
Weighted Average Basic Shares Outstanding		 115.16M 115.16M 115.34M 116.87M 133.41M 168.46M
Diluted Earnings per Share		 $0.37 $1.30 $0.79 $0.03 ($2.17) ($0.59)
Weighted Average Diluted Shares Outstanding		 115.16M 115.16M 115.79M 119.46M 133.41M 168.46M
Weighted Average Basic & Diluted Shares Outstanding		 - - 116.60M 117.09M 163.33M 164.19M

Quarterly Income Statements for RXO

This table shows RXO's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -1.00 2.00 -15 -7.00 -243 -27 -31 -9.00 -14 -46 -36
Consolidated Net Income / (Loss)		 -1.00 2.00 -15 -7.00 -243 -25 -31 -9.00 -14 -46 -36
Net Income / (Loss) Continuing Operations		 -1.00 2.00 -15 -7.00 -243 -27 -31 -9.00 -14 -46 -36
Total Pre-Tax Income 		-3.00 4.00 -21 -8.00 -242 -33 -39 -10 -15 -51 -49
Total Operating Income		 6.00 14 -12 0.00 -20 -24 -30 0.00 -7.00 -42 -28
Total Gross Profit		 234 235 214 230 231 310 280 301 284 266 254
Total Revenue		 976 978 913 930 1,040 1,667 1,433 1,419 1,421 1,469 1,425
Operating Revenue		 976 978 913 930 1,040 1,667 1,433 1,419 1,421 1,469 1,425
Total Cost of Revenue		 742 743 699 700 809 1,357 1,153 1,118 1,137 1,203 1,171
Operating Cost of Revenue		 742 743 699 700 809 1,357 1,153 1,118 1,137 1,203 1,171
Total Operating Expenses		 228 221 226 230 251 334 310 301 291 308 282
Selling, General & Admin Expense		 148 146 145 154 149 218 210 214 208 200 197
Depreciation Expense		 16 15 16 17 21 33 32 30 26 28 26
Other Operating Expenses / (Income)		 59 56 53 50 49 50 48 47 48 47 50
Restructuring Charge		 5.00 4.00 12 9.00 32 33 20 10 9.00 21 9.00
Total Other Income / (Expense), net		 -9.00 -10 -9.00 -8.00 -222 -11 -9.00 -10 -8.00 -9.00 -21
Interest Expense		 - - - - - - 0.00 - - - 11
Interest & Investment Income		 -8.00 -8.00 -8.00 -8.00 -6.00 -8.00 -9.00 -8.00 -9.00 -9.00 -9.00
Other Income / (Expense), net		 -1.00 -2.00 -1.00 0.00 -216 -3.00 0.00 -2.00 1.00 - -1.00
Income Tax Expense		 -2.00 2.00 -6.00 -1.00 1.00 -8.00 -8.00 -1.00 -1.00 -5.00 -13
Basic Earnings per Share		 ($0.01) $0.01 ($0.13) ($0.06) ($1.81) ($0.17) ($0.18) ($0.05) ($0.08) ($0.28) ($0.21)
Weighted Average Basic Shares Outstanding		 116.97M 116.87M 117.22M 117.58M 134.10M 133.41M 168.02M 168.53M 168.58M 168.46M 169.10M
Diluted Earnings per Share		 ($0.01) $0.01 ($0.13) ($0.06) ($1.81) ($0.17) ($0.18) ($0.05) ($0.08) ($0.28) ($0.21)
Weighted Average Diluted Shares Outstanding		 116.97M 119.46M 117.22M 117.58M 134.10M 133.41M 168.02M 168.53M 168.58M 168.46M 169.10M
Weighted Average Basic & Diluted Shares Outstanding		 117.00M 117.09M 117.55M 117.63M 160.79M 163.33M 163.92M 163.99M 164.11M 164.19M 164.92M

Annual Cash Flow Statements for RXO

This table details how cash moves in and out of RXO's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 19 -41 69 -93 30 -17
Net Cash From Operating Activities		 25 155 310 89 -12 51
Net Cash From Continuing Operating Activities		 25 155 310 89 -12 51
Net Income / (Loss) Continuing Operations		 43 150 92 4.00 -290 -100
Consolidated Net Income / (Loss)		 43 150 92 4.00 -290 -100
Depreciation Expense		 76 81 86 67 87 116
Non-Cash Adjustments To Reconcile Net Income		 22 11 38 28 259 56
Changes in Operating Assets and Liabilities, net		 -116 -87 94 -10 -68 -21
Net Cash From Investing Activities		 -39 -38 -56 -66 -1,064 -71
Net Cash From Continuing Investing Activities		 -39 -38 -56 -66 -1,064 -71
Purchase of Property, Plant & Equipment		 -47 -39 -57 -64 -45 -59
Acquisitions		 - - 0.00 0.00 -1,019 -10
Sale of Property, Plant & Equipment		 8.00 1.00 1.00 0.00 0.00 2.00
Other Investing Activities, net		 - 0.00 0.00 -2.00 0.00 -4.00
Net Cash From Financing Activities		 32 -158 -183 -117 1,108 1.00
Net Cash From Continuing Financing Activities		 32 -158 -183 -117 1,108 1.00
Repayment of Debt		 0.00 1.00 -10 -177 -221 -545
Repurchase of Common Equity		 - 0.00 0.00 -2.00 -30 -1.00
Issuance of Debt		 0.00 0.00 451 76 238 566
Issuance of Common Equity		 - - 0.00 0.00 1,125 0.00
Other Financing Activities, net		 32 -159 -624 -14 -4.00 -19
Effect of Exchange Rate Changes		 1.00 0.00 -2.00 1.00 -2.00 2.00
Cash Interest Paid		 - 0.00 0.00 32 27 32
Cash Income Taxes Paid		 2.00 5.00 3.00 27 4.00 7.00

Quarterly Cash Flow Statements for RXO

This table details how cash moves in and out of RXO's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -20 -99 2.00 - 48 -20 -19 3.00 7.00 -8.00 4.00
Net Cash From Operating Activities		 4.00 19 7.00 -5.00 -7.00 -7.00 -2.00 23 23 7.00 -7.00
Net Cash From Continuing Operating Activities		 4.00 19 7.00 -5.00 -7.00 -7.00 -2.00 23 23 7.00 -7.00
Net Income / (Loss) Continuing Operations		 -1.00 2.00 -15 -7.00 -243 -25 -31 -9.00 -14 -46 -36
Consolidated Net Income / (Loss)		 -1.00 2.00 -15 -7.00 -243 -25 -31 -9.00 -14 -46 -36
Depreciation Expense		 16 15 16 17 21 33 32 30 26 28 26
Non-Cash Adjustments To Reconcile Net Income		 8.00 8.00 7.00 6.00 223 23 13 11 8.00 24 24
Changes in Operating Assets and Liabilities, net		 -19 -6.00 -1.00 -21 -8.00 -38 -16 -9.00 3.00 1.00 -21
Net Cash From Investing Activities		 -19 -19 -11 -11 -1,030 -12 -25 -18 -13 -15 -17
Net Cash From Continuing Investing Activities		 -19 -19 -11 -11 -1,030 -12 -25 -18 -13 -15 -17
Purchase of Property, Plant & Equipment		 -18 -18 -11 -11 -11 -12 -15 -14 -14 -16 -17
Acquisitions		 - - 0.00 - - - -10 - - - 0.00
Net Cash From Financing Activities		 -4.00 -100 6.00 16 1,085 1.00 7.00 -3.00 -3.00 - 28
Net Cash From Continuing Financing Activities		 -4.00 -100 6.00 16 1,085 1.00 7.00 -3.00 -3.00 - 28
Repayment of Debt		 -1.00 -174 -31 -63 -93 -34 -276 38 -211 -96 -695
Issuance of Debt		 - 76 39 80 84 35 300 -39 210 95 725
Other Financing Activities, net		 -3.00 -2.00 -2.00 -1.00 -1.00 - -17 -1.00 -2.00 1.00 -2.00
Effect of Exchange Rate Changes		 -1.00 1.00 0.00 - - -2.00 1.00 1.00 - - 0.00
Cash Interest Paid		 1.00 14 1.00 14 -2.00 14 2.00 14 1.00 15 8.00
Cash Income Taxes Paid		 4.00 2.00 1.00 1.00 1.00 1.00 1.00 3.00 2.00 1.00 1.00

Annual Balance Sheets for RXO

This table presents RXO's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 2,068 2,031 1,825 3,414 3,277
Total Current Assets		 1,083 1,029 796 1,339 1,317
Cash & Equivalents		 29 98 5.00 35 17
Accounts Receivable		 1,010 900 743 1,227 1,226
Other Current Assets		 44 31 48 77 74
Plant, Property, & Equipment, net		 0.00 119 124 135 134
Total Noncurrent Assets		 985 883 905 1,940 1,826
Goodwill		 630 630 630 1,123 1,111
Intangible Assets		 100 79 68 499 453
Other Noncurrent Operating Assets		 255 174 207 318 262
Total Liabilities & Shareholders' Equity		 2,068 2,031 1,825 3,414 3,277
Total Liabilities		 998 1,444 1,231 1,802 1,736
Total Current Liabilities		 816 823 682 1,065 1,038
Short-Term Debt		 0.00 4.00 3.00 17 17
Accounts Payable		 520 501 414 568 539
Accrued Expenses		 248 256 199 373 397
Other Current Liabilities		 48 62 66 107 85
Total Noncurrent Liabilities		 182 621 549 737 698
Long-Term Debt		 0.00 451 356 351 387
Noncurrent Deferred & Payable Income Tax Liabilities		 52 16 7.00 88 51
Other Noncurrent Operating Liabilities		 130 154 186 298 260
Commitments & Contingencies		 - 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,070 587 594 1,612 1,541
Total Preferred & Common Equity		 1,070 587 594 1,612 1,541
Preferred Stock		 - 0.00 0.00 0.00 0.00
Total Common Equity		 1,070 587 594 1,612 1,541
Common Stock		 - 589 591 1,906 1,931
Retained Earnings		 - 2.00 6.00 -284 -384
Accumulated Other Comprehensive Income / (Loss)		 -2.00 -4.00 -3.00 -10 -6.00

Quarterly Balance Sheets for RXO

This table presents RXO's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 2,237 2,018 1,912 1,946 1,799 1,813 3,392 3,304 3,201 3,201 3,268
Total Current Assets		 1,225 1,029 916 936 770 776 1,255 1,255 1,184 1,201 1,335
Cash & Equivalents		 187 121 124 104 7.00 7.00 55 16 18 25 21
Accounts Receivable		 1,012 862 743 787 716 725 1,138 1,150 1,065 1,104 1,216
Other Current Assets		 26 46 49 45 47 44 62 89 101 72 98
Plant, Property, & Equipment, net		 0.00 0.00 116 122 121 118 175 143 137 137 131
Total Noncurrent Assets		 1,012 989 880 888 908 919 1,962 1,906 1,880 1,863 1,802
Goodwill		 630 630 630 630 630 630 1,027 1,124 1,125 1,123 1,111
Intangible Assets		 85 76 73 72 65 62 565 484 474 463 442
Other Noncurrent Operating Assets		 297 283 177 186 213 227 370 298 281 277 249
Total Liabilities & Shareholders' Equity		 2,237 2,018 1,912 1,946 1,799 1,813 3,392 3,304 3,201 3,201 3,268
Total Liabilities		 1,093 1,433 1,323 1,356 1,217 1,234 1,740 1,717 1,613 1,621 1,759
Total Current Liabilities		 888 820 699 728 674 662 947 964 880 907 1,048
Short-Term Debt		 5.00 4.00 4.00 3.00 16 16 15 17 16 16 17
Accounts Payable		 547 496 432 448 372 382 572 498 461 481 584
Accrued Expenses		 284 265 210 221 220 197 262 358 315 321 367
Other Current Liabilities		 52 55 53 56 66 67 98 91 88 89 80
Total Noncurrent Liabilities		 205 613 624 628 543 572 793 753 733 714 711
Long-Term Debt		 6.00 451 451 451 351 370 352 387 387 387 430
Noncurrent Deferred & Payable Income Tax Liabilities		 44 16 17 15 1.00 0.00 115 77 75 54 36
Other Noncurrent Operating Liabilities		 155 146 156 162 191 202 326 289 271 273 245
Commitments & Contingencies		 - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,144 -4.00 589 590 582 579 1,652 1,587 1,588 1,580 1,509
Total Preferred & Common Equity		 1,144 585 589 590 582 579 1,652 1,587 1,588 1,580 1,509
Preferred Stock		 - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 1,144 -4.00 589 590 582 579 1,652 1,587 1,588 1,580 1,509
Common Stock		 - - 588 590 594 600 1,916 1,910 1,917 1,924 1,936
Retained Earnings		 - - 5.00 4.00 -9.00 -16 -259 -315 -324 -338 -420
Accumulated Other Comprehensive Income / (Loss)		 -4.00 -4.00 -4.00 -4.00 -3.00 -5.00 -5.00 -8.00 -5.00 -6.00 -7.00

Annual Metrics And Ratios for RXO

This table displays calculated financial ratios and metrics derived from RXO's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - -
Revenue Growth		 0.00% 39.68% 2.28% -18.12% 15.86% 26.20%
EBITDA Growth		 0.00% 104.51% -23.16% -50.72% -281.55% 119.25%
EBIT Growth		 0.00% 235.09% -35.60% -70.73% -861.11% 70.80%
NOPAT Growth		 0.00% 233.13% -36.94% -58.99% -200.51% -41.07%
Net Income Growth		 0.00% 248.84% -38.67% -95.65% -7,350.00% 65.52%
EPS Growth		 0.00% 251.35% -39.23% -96.20% -7,333.33% 72.81%
Operating Cash Flow Growth		 0.00% 520.00% 100.00% -71.29% -113.48% 525.00%
Free Cash Flow Firm Growth		 0.00% 0.00% 121.58% -81.78% -3,060.57% 96.30%
Invested Capital Growth		 0.00% 0.00% -9.32% 0.42% 105.17% -0.87%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% -3.49% 17.85% -3.33%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 6.19% -12.65% -37.93%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 50.00% -16.60% -26.98%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 132.14% -211.11% -29.51%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 300.00% -10.27% -26.58%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 250.00% -9.05% -22.92%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 14.81% -39.04% -185.71% 37.84%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.04% -4.36%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.85% -0.97% -1.53%
Profitability Metrics		 - - - - - -
Gross Margin		 23.50% 21.50% 24.44% 24.45% 21.65% 19.70%
EBITDA Margin		 3.96% 5.80% 4.36% 2.62% -4.11% 0.63%
Operating Margin		 1.79% 4.09% 2.56% 0.99% -1.23% -1.38%
EBIT Margin		 1.70% 4.07% 2.56% 0.92% -6.02% -1.39%
Profit (Net Income) Margin		 1.28% 3.20% 1.92% 0.10% -6.37% -1.74%
Tax Burden Percent		 75.44% 78.53% 77.31% 100.00% 95.39% 86.96%
Interest Burden Percent		 100.00% 100.00% 96.75% 11.11% 110.95% 143.75%
Effective Tax Rate		 24.56% 21.47% 22.69% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 28.97% 9.58% 4.12% -2.71% -2.86%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 34.39% 7.70% -5.72% -75.72% -15.27%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -0.93% 1.52% -3.45% -23.58% -3.49%
Return on Equity (ROE)		 0.00% 28.04% 11.10% 0.68% -26.29% -6.34%
Cash Return on Invested Capital (CROIC)		 0.00% -171.03% 19.35% 3.70% -71.64% -1.98%
Operating Return on Assets (OROA)		 0.00% 9.24% 6.00% 1.87% -10.46% -2.39%
Return on Assets (ROA)		 0.00% 7.25% 4.49% 0.21% -11.07% -2.99%
Return on Common Equity (ROCE)		 0.00% 28.04% 11.10% 0.68% -26.29% -6.34%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 14.02% 15.67% 0.67% -17.99% 0.00%
Net Operating Profit after Tax (NOPAT)		 45 151 95 39 -39 -55
NOPAT Margin		 1.35% 3.22% 1.98% 0.99% -0.86% -0.96%
Net Nonoperating Expense Percent (NNEP)		 0.00% -5.42% 1.89% 9.85% 73.01% 12.42%
Return On Investment Capital (ROIC_SIMPLE)		 - - 9.13% 4.09% -1.98% -2.84%
Cost of Revenue to Revenue		 76.50% 78.50% 75.56% 75.55% 78.35% 80.30%
SG&A Expenses to Revenue		 13.55% 11.50% 13.34% 15.05% 14.64% 14.49%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 21.72% 17.40% 21.87% 23.45% 22.88% 21.07%
Earnings before Interest and Taxes (EBIT)		 57 191 123 36 -274 -80
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 133 272 209 103 -187 36
Valuation Ratios		 - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 3.41 4.58 2.38 1.35
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.42 0.69 0.84 0.36
Price to Earnings (P/E)		 0.00 0.00 21.74 680.36 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 4.60% 0.15% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 2.50 3.24 2.14 1.28
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.49 0.78 0.92 0.43
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 11.28 29.86 0.00 68.37
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 19.17 85.43 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 24.79 78.86 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 7.60 34.56 0.00 48.26
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 12.27 87.87 0.00 0.00
Leverage & Solvency		 - - - - - -
Debt to Equity		 0.00 0.00 0.78 0.60 0.23 0.26
Long-Term Debt to Equity		 0.00 0.00 0.77 0.60 0.22 0.25
Financial Leverage		 0.00 -0.03 0.20 0.60 0.31 0.23
Leverage Ratio		 0.00 1.93 2.47 3.27 2.37 2.12
Compound Leverage Factor		 0.00 1.93 2.39 0.36 2.63 3.05
Debt to Total Capital		 0.00% 0.00% 43.67% 37.67% 18.59% 20.77%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.38% 0.31% 0.86% 0.87%
Long-Term Debt to Total Capital		 0.00% 0.00% 43.28% 37.36% 17.73% 19.90%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 100.00% 56.33% 62.33% 81.41% 79.23%
Debt to EBITDA		 0.00 0.00 2.18 3.49 -1.97 11.22
Net Debt to EBITDA		 0.00 0.00 1.71 3.44 -1.78 10.75
Long-Term Debt to EBITDA		 0.00 0.00 2.16 3.46 -1.88 10.75
Debt to NOPAT		 0.00 0.00 4.78 9.21 -9.39 -7.31
Net Debt to NOPAT		 0.00 0.00 3.75 9.08 -8.49 -7.00
Long-Term Debt to NOPAT		 0.00 0.00 4.74 9.13 -8.95 -7.00
Altman Z-Score		 0.00 0.00 3.52 3.62 2.32 2.33
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - -
Current Ratio		 0.00 1.33 1.25 1.17 1.26 1.27
Quick Ratio		 0.00 1.27 1.21 1.10 1.19 1.20
Cash Flow Metrics		 - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -890 192 35 -1,036 -38
Operating Cash Flow to CapEx		 64.10% 407.89% 553.57% 139.06% -26.67% 89.47%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - -
Asset Turnover		 0.00 2.27 2.34 2.04 1.74 1.72
Accounts Receivable Turnover		 0.00 4.64 5.02 4.78 4.62 4.68
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 32.32 35.14 42.69
Accounts Payable Turnover		 0.00 7.08 7.10 6.49 7.26 8.33
Days Sales Outstanding (DSO)		 0.00 78.62 72.68 76.36 79.02 77.96
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 51.56 51.42 56.28 50.27 43.81
Cash Conversion Cycle (CCC)		 0.00 27.06 21.26 20.07 28.75 34.15
Capital & Investment Metrics		 - - - - - -
Invested Capital		 0.00 1,041 944 948 1,945 1,928
Invested Capital Turnover		 0.00 9.01 4.83 4.15 3.15 2.97
Increase / (Decrease) in Invested Capital		 0.00 1,041 -97 4.00 997 -17
Enterprise Value (EV)		 0.00 0.00 2,357 3,075 4,166 2,461
Market Capitalization		 0.00 0.00 2,000 2,721 3,833 2,074
Book Value per Share		 $0.00 $9.29 $5.05 $5.08 $10.03 $9.39
Tangible Book Value per Share		 $0.00 $2.95 ($1.05) ($0.89) ($0.06) ($0.14)
Total Capital		 0.00 1,070 1,042 953 1,980 1,945
Total Debt		 0.00 0.00 455 359 368 404
Total Long-Term Debt		 0.00 0.00 451 356 351 387
Net Debt		 0.00 -29 357 354 333 387
Capital Expenditures (CapEx)		 39 38 56 64 45 57
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 238 112 112 256 279
Debt-free Net Working Capital (DFNWC)		 0.00 267 210 117 291 296
Net Working Capital (NWC)		 0.00 267 206 114 274 279
Net Nonoperating Expense (NNE)		 2.26 0.79 3.09 35 251 45
Net Nonoperating Obligations (NNO)		 0.00 -29 357 354 333 387
Total Depreciation and Amortization (D&A)		 76 81 86 67 87 116
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 5.08% 2.34% 2.85% 5.63% 4.86%
Debt-free Net Working Capital to Revenue		 0.00% 5.69% 4.38% 2.98% 6.40% 5.16%
Net Working Capital to Revenue		 0.00% 5.69% 4.30% 2.90% 6.02% 4.86%
Earnings Adjustments		 - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.80 $0.03 ($2.17) ($0.59)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 115.34M 116.87M 133.41M 168.46M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.79 $0.03 ($2.17) ($0.59)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 115.79M 119.46M 133.41M 168.46M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 116.60M 117.09M 163.33M 164.19M
Normalized Net Operating Profit after Tax (NOPAT)		 63 154 170 47 21 -4.90
Normalized NOPAT Margin		 1.89% 3.28% 3.55% 1.19% 0.46% -0.09%
Pre Tax Income Margin		 1.70% 4.07% 2.48% 0.10% -6.68% -2.00%
Debt Service Ratios		 - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 50.00% -10.34% -1.00%

Quarterly Metrics And Ratios for RXO

This table displays calculated financial ratios and metrics derived from RXO's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 164,193,961.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 164,193,961.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - -0.22
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -14.24% -12.68% -9.60% -3.43% 6.56% 70.45% 56.96% 52.58% 36.63% -11.88% -0.56%
EBITDA Growth		 -46.15% 35.00% -78.26% -46.88% -1,123.81% -77.78% -33.33% 64.71% 109.30% -275.00% -250.00%
EBIT Growth		 -68.75% 1,300.00% -320.00% -100.00% -4,820.00% -325.00% -130.77% 0.00% 97.46% -68.00% 3.33%
NOPAT Growth		 -67.69% 1,100.00% -340.00% -100.00% -433.33% -340.00% -150.00% 0.00% 65.00% -75.00% 6.67%
Net Income Growth		 -107.69% 150.00% 0.00% -333.33% -24,200.00% -1,350.00% -106.67% -28.57% 94.24% -84.00% -16.13%
EPS Growth		 -109.09% 125.00% 0.00% -300.00% -18,000.00% -1,800.00% -38.46% 16.67% 95.58% -64.71% -16.67%
Operating Cash Flow Growth		 -92.98% -75.00% -83.33% -120.83% -275.00% -136.84% -128.57% 560.00% 428.57% 200.00% -250.00%
Free Cash Flow Firm Growth		 103.37% 0.00% 96.57% 95.84% -3,323.60% -33,893.33% -3,256.69% -2,571.05% 100.11% 98.78% 101.94%
Invested Capital Growth		 -2.89% 0.42% 2.50% 4.13% 108.94% 105.17% 109.66% 105.95% -0.31% -0.87% -2.03%
Revenue Q/Q Growth		 1.35% 0.20% -6.65% 1.86% 11.83% 60.29% -14.04% -0.98% 0.14% 3.38% -3.00%
EBITDA Q/Q Growth		 -34.38% 28.57% -80.00% 240.00% -1,364.71% 102.79% -66.67% 1,300.00% -28.57% -170.00% 78.57%
EBIT Q/Q Growth		 -64.29% 140.00% -210.00% 100.00% 0.00% 88.56% -11.11% 93.33% -200.00% -600.00% 30.95%
NOPAT Q/Q Growth		 -40.00% 66.67% -220.00% 100.00% 0.00% -20.00% -25.00% 100.00% 0.00% -500.00% 33.33%
Net Income Q/Q Growth		 -133.33% 300.00% -850.00% 53.33% -3,371.43% 89.71% -24.00% 70.97% -55.56% -228.57% 21.74%
EPS Q/Q Growth		 -133.33% 200.00% -1,400.00% 53.85% -2,916.67% 90.61% -5.88% 72.22% -60.00% -250.00% 25.00%
Operating Cash Flow Q/Q Growth		 -83.33% 375.00% -63.16% -171.43% -40.00% 0.00% 71.43% 1,250.00% 0.00% -69.57% -200.00%
Free Cash Flow Firm Q/Q Growth		 103.53% -90.68% -1,146.67% -21.02% -2,631.58% 2.33% -3.97% 3.70% 100.11% -1,227.27% 264.52%
Invested Capital Q/Q Growth		 2.17% 0.85% -0.63% 1.70% 105.01% -0.97% 1.54% -0.10% -0.76% -1.53% 0.36%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 23.98% 24.03% 23.44% 24.73% 22.21% 18.60% 19.54% 21.21% 19.99% 18.11% 17.82%
EBITDA Margin		 2.15% 2.76% 0.55% 1.83% -20.67% 0.36% 0.14% 1.97% 1.41% -0.95% -0.21%
Operating Margin		 0.61% 1.43% -1.31% 0.00% -1.92% -1.44% -2.09% 0.00% -0.49% -2.86% -1.96%
EBIT Margin		 0.51% 1.23% -1.20% 0.00% -22.69% -1.62% -2.09% -0.14% -0.42% -2.86% -2.04%
Profit (Net Income) Margin		 -0.10% 0.20% -1.64% -0.75% -23.37% -1.50% -2.16% -0.63% -0.99% -3.13% -2.53%
Tax Burden Percent		 33.33% 50.00% 71.43% 87.50% 100.41% 75.76% 79.49% 90.00% 93.33% 90.20% 73.47%
Interest Burden Percent		 -60.00% 33.33% 190.91% 0.00% 102.54% 122.22% 130.00% 500.00% 250.00% 121.43% 168.97%
Effective Tax Rate		 0.00% 50.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 1.84% 2.97% -3.79% 0.00% -3.58% -3.17% -5.09% 0.00% -1.04% -5.93% -4.03%
ROIC Less NNEP Spread (ROIC-NNEP)		 -4.14% 1.56% -4.82% -1.97% -72.76% -5.56% -7.77% -2.36% -3.68% -10.55% -8.06%
Return on Net Nonoperating Assets (RNNOA)		 -0.42% 0.94% -10.69% -1.20% -21.49% -1.73% -2.68% -0.83% -0.79% -2.41% -2.12%
Return on Equity (ROE)		 1.42% 3.91% -14.48% -1.20% -25.06% -4.90% -7.77% -0.83% -1.83% -8.34% -6.15%
Cash Return on Invested Capital (CROIC)		 0.00% 3.70% -0.82% -3.45% -71.39% -71.64% -74.38% -72.79% -1.87% -1.98% -0.71%
Operating Return on Assets (OROA)		 1.00% 2.50% -2.42% 0.00% -32.83% -2.81% -4.16% -0.31% -0.76% -4.91% -3.55%
Return on Assets (ROA)		 -0.20% 0.42% -3.30% -1.53% -33.80% -2.60% -4.30% -1.41% -1.78% -5.37% -4.41%
Return on Common Equity (ROCE)		 1.42% 3.91% -14.48% -1.20% -25.06% -4.90% -7.77% -0.83% -1.83% -8.34% -6.15%
Return on Equity Simple (ROE_SIMPLE)		 -0.34% 0.00% -1.89% -3.63% -15.92% 0.00% -19.28% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 4.20 7.00 -8.40 0.00 -14 -17 -21 0.00 -4.90 -29 -20
NOPAT Margin		 0.43% 0.72% -0.92% 0.00% -1.35% -1.01% -1.47% 0.00% -0.34% -2.00% -1.38%
Net Nonoperating Expense Percent (NNEP)		 5.98% 1.41% 1.03% 1.97% 69.18% 2.39% 2.67% 2.36% 2.64% 4.61% 4.03%
Return On Investment Capital (ROIC_SIMPLE)		 - 0.73% - - - -0.85% -1.05% 0.00% -0.25% -1.51% -1.00%
Cost of Revenue to Revenue		 76.02% 75.97% 76.56% 75.27% 77.79% 81.40% 80.46% 78.79% 80.01% 81.89% 82.18%
SG&A Expenses to Revenue		 15.16% 14.93% 15.88% 16.56% 14.33% 13.08% 14.65% 15.08% 14.64% 13.61% 13.82%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 23.36% 22.60% 24.75% 24.73% 24.13% 20.04% 21.63% 21.21% 20.48% 20.97% 19.79%
Earnings before Interest and Taxes (EBIT)		 5.00 12 -11 0.00 -236 -27 -30 -2.00 -6.00 -42 -29
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 21 27 5.00 17 -215 6.00 2.00 28 20 -14 -3.00
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.91 4.58 4.40 5.31 1.99 2.38 1.97 1.62 1.60 1.35 1.59
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 54.89 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.57 0.69 0.67 0.81 0.85 0.84 0.62 0.46 0.42 0.36 0.42
Price to Earnings (P/E)		 0.00 680.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.15% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 2.83 3.24 3.10 3.60 1.84 2.14 1.78 1.50 1.48 1.28 1.46
Enterprise Value to Revenue (EV/Rev)		 0.65 0.78 0.76 0.91 0.93 0.92 0.69 0.53 0.49 0.43 0.49
Enterprise Value to EBITDA (EV/EBITDA)		 27.40 29.86 34.34 49.33 0.00 0.00 0.00 0.00 50.00 68.37 91.18
Enterprise Value to EBIT (EV/EBIT)		 110.75 85.43 145.94 575.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 158.22 78.86 189.53 616.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.21 34.56 54.05 138.12 257.54 0.00 0.00 423.11 78.38 48.26 61.45
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 87.87 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.77 0.60 0.63 0.67 0.22 0.23 0.25 0.25 0.26 0.26 0.30
Long-Term Debt to Equity		 0.76 0.60 0.60 0.64 0.21 0.22 0.24 0.24 0.24 0.25 0.29
Financial Leverage		 0.10 0.60 2.22 0.61 0.30 0.31 0.34 0.35 0.21 0.23 0.26
Leverage Ratio		 2.41 3.27 6.60 3.19 2.38 2.37 2.35 2.31 2.04 2.12 2.12
Compound Leverage Factor		 -1.45 1.09 12.61 0.00 2.44 2.90 3.06 11.57 5.10 2.58 3.59
Debt to Total Capital		 43.49% 37.67% 38.67% 40.00% 18.18% 18.59% 20.29% 20.24% 20.32% 20.77% 22.85%
Short-Term Debt to Total Capital		 0.29% 0.31% 1.69% 1.66% 0.74% 0.86% 0.85% 0.80% 0.81% 0.87% 0.87%
Long-Term Debt to Total Capital		 43.20% 37.36% 36.99% 38.34% 17.43% 17.73% 19.44% 19.44% 19.52% 19.90% 21.98%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 56.51% 62.33% 61.33% 60.00% 81.82% 81.41% 79.71% 79.76% 79.68% 79.23% 77.15%
Debt to EBITDA		 4.68 3.49 4.32 5.51 -2.21 -1.97 -2.15 -2.28 6.95 11.22 14.42
Net Debt to EBITDA		 3.61 3.44 4.24 5.41 -1.88 -1.78 -2.06 -2.18 6.52 10.75 13.74
Long-Term Debt to EBITDA		 4.65 3.46 4.13 5.29 -2.12 -1.88 -2.06 -2.19 6.67 10.75 13.87
Debt to NOPAT		 27.02 9.21 23.83 68.93 -29.13 -9.39 -7.80 -7.78 -9.44 -7.31 -8.29
Net Debt to NOPAT		 20.83 9.08 23.38 67.68 -24.76 -8.49 -7.49 -7.43 -8.85 -7.00 -7.90
Long-Term Debt to NOPAT		 26.85 9.13 22.79 66.07 -27.94 -8.95 -7.47 -7.47 -9.06 -7.00 -7.98
Altman Z-Score		 3.25 3.58 3.43 3.65 2.05 2.56 2.57 2.67 2.75 2.37 2.47
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.29 1.17 1.14 1.17 1.33 1.26 1.30 1.35 1.32 1.27 1.27
Quick Ratio		 1.22 1.10 1.07 1.11 1.26 1.19 1.21 1.23 1.24 1.20 1.18
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 32 3.00 -31 -38 -1,038 -1,014 -1,054 -1,015 1.10 -12 20
Operating Cash Flow to CapEx		 22.22% 105.56% 63.64% -45.45% -63.64% -58.33% -13.33% 164.29% 164.29% 46.67% -41.18%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.85
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.64
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.18
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.95 2.04 2.01 2.04 1.45 1.74 1.99 2.22 1.80 1.72 1.75
Accounts Receivable Turnover		 4.52 4.78 4.85 5.17 4.01 4.62 5.43 6.21 5.30 4.68 4.85
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 32.32 0.00 32.45 26.00 35.14 38.41 43.60 38.08 42.69 41.85
Accounts Payable Turnover		 6.16 6.49 6.70 7.09 5.79 7.26 9.24 10.53 9.05 8.33 8.56
Days Sales Outstanding (DSO)		 80.69 76.36 75.19 70.56 90.99 79.02 67.17 58.77 68.88 77.96 75.30
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 59.23 56.28 54.49 51.51 63.08 50.27 39.51 34.67 40.33 43.81 42.66
Cash Conversion Cycle (CCC)		 21.46 20.07 20.70 19.05 27.91 28.75 27.66 24.09 28.55 34.15 32.65
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 940 948 942 958 1,964 1,945 1,975 1,973 1,958 1,928 1,935
Invested Capital Turnover		 4.27 4.15 4.12 4.04 2.66 3.15 3.48 3.79 3.03 2.97 2.93
Increase / (Decrease) in Invested Capital		 -28 4.00 23 38 1,024 997 1,033 1,015 -6.00 -17 -40
Enterprise Value (EV)		 2,658 3,075 2,919 3,453 3,606 4,166 3,508 2,962 2,900 2,461 2,827
Market Capitalization		 2,308 2,721 2,559 3,074 3,294 3,833 3,120 2,577 2,522 2,074 2,401
Book Value per Share		 $5.04 $5.08 $4.97 $4.93 $14.04 $10.03 $9.72 $9.69 $9.63 $9.39 $9.19
Tangible Book Value per Share		 ($0.96) ($0.89) ($0.96) ($0.96) $0.51 ($0.06) ($0.13) ($0.07) ($0.04) ($0.14) ($0.27)
Total Capital		 1,044 953 949 965 2,019 1,980 1,991 1,991 1,983 1,945 1,956
Total Debt		 454 359 367 386 367 368 404 403 403 404 447
Total Long-Term Debt		 451 356 351 370 352 351 387 387 387 387 430
Net Debt		 350 354 360 379 312 333 388 385 378 387 426
Capital Expenditures (CapEx)		 18 18 11 11 11 12 15 14 14 15 17
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 107 112 105 123 268 256 292 302 285 279 283
Debt-free Net Working Capital (DFNWC)		 211 117 112 130 323 291 308 320 310 296 304
Net Working Capital (NWC)		 208 114 96 114 308 274 291 304 294 279 287
Net Nonoperating Expense (NNE)		 5.20 5.00 6.60 7.00 229 8.20 10 9.00 9.10 17 16
Net Nonoperating Obligations (NNO)		 350 354 360 379 312 333 388 385 378 387 426
Total Depreciation and Amortization (D&A)		 16 15 16 17 21 33 32 30 26 28 26
Debt-free, Cash-free Net Working Capital to Revenue		 2.63% 2.85% 2.74% 3.24% 6.94% 5.63% 5.76% 5.43% 4.80% 4.86% 4.94%
Debt-free Net Working Capital to Revenue		 5.19% 2.98% 2.92% 3.42% 8.37% 6.40% 6.08% 5.76% 5.22% 5.16% 5.30%
Net Working Capital to Revenue		 5.11% 2.90% 2.51% 3.00% 7.98% 6.02% 5.74% 5.47% 4.95% 4.86% 5.01%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.01) $0.01 ($0.13) ($0.06) ($1.81) ($0.17) ($0.18) ($0.05) ($0.08) ($0.28) ($0.21)
Adjusted Weighted Average Basic Shares Outstanding		 116.97M 116.87M 117.22M 117.58M 134.10M 133.41M 168.02M 168.53M 168.58M 168.46M 169.10M
Adjusted Diluted Earnings per Share		 ($0.01) $0.01 ($0.13) ($0.06) ($1.81) ($0.17) ($0.18) ($0.05) ($0.08) ($0.28) ($0.21)
Adjusted Weighted Average Diluted Shares Outstanding		 116.97M 119.46M 117.22M 117.58M 134.10M 133.41M 168.02M 168.53M 168.58M 168.46M 169.10M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 117.00M 117.09M 117.55M 117.63M 160.79M 163.33M 163.92M 163.99M 164.11M 164.19M 164.92M
Normalized Net Operating Profit after Tax (NOPAT)		 7.70 9.00 0.00 6.30 8.40 6.30 -7.00 7.00 1.40 -15 -13
Normalized NOPAT Margin		 0.79% 0.92% 0.00% 0.68% 0.81% 0.38% -0.49% 0.49% 0.10% -1.00% -0.93%
Pre Tax Income Margin		 -0.31% 0.41% -2.30% -0.86% -23.27% -1.98% -2.72% -0.70% -1.06% -3.47% -3.44%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.64
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.78
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -4.18
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -3.33
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -100.00% 50.00% 0.00% 0.00% 0.00% -10.34% 0.00% 0.00% 0.00% -1.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

RXO’s recent financial trend has been mixed, with some improvement in profitability and cash flow in early 2026, but the company is still operating at a loss and carrying a fairly leveraged balance sheet. Over the last several quarters, revenue has been relatively steady to slightly lower, margins have improved from the weak 2024 period, and operating cash flow has turned positive again. However, RXO continues to struggle with inconsistent earnings, restructuring charges, and a heavy working-capital burden tied to receivables and payables.

What looks positive:

  • Q1 2026 operating cash flow improved to a $7 million outflow from a $7 million inflow in Q4 2025 and a $23 million inflow in Q3 2025, showing the business is at least close to breakeven on a cash basis.
  • Gross profit margin improved meaningfully in Q1 2026, with gross profit of $254 million on $1.425 billion in revenue, better than Q4 2025 and roughly in line with late-2025 performance.
  • Operating losses narrowed sharply versus 2024’s weakest quarter. RXO reported an operating loss of only $28 million in Q1 2026 versus $42 million in Q4 2025 and a much larger loss in Q3 2024.
  • The company ended Q1 2026 with $1.5 billion in common equity, indicating it still has substantial book equity support despite recent losses.
  • Long-term debt declined to $430 million in Q1 2026 from $451 million in Q1 2025 and $387 million in Q3/Q4 2025, suggesting some balance-sheet deleveraging.
  • Revenue has been relatively resilient, staying in a fairly tight range around $1.4 billion to $1.5 billion in recent quarters after a softer 2024.

What looks neutral:

  • Accounts receivable remains very large at $1.216 billion in Q1 2026, which is normal for a logistics business but keeps working capital management important.
  • Cash was only $21 million at Q1 2026, so the company is not carrying a large cash cushion on the balance sheet.
  • The company continues to rely on debt markets and refinancings, with Q1 2026 showing both $725 million of debt issuance and $695 million of repayments.
  • Depreciation and other non-cash charges continue to support reported cash flow, so earnings quality should be watched closely.

What looks negative:

  • RXO posted a $36 million net loss in Q1 2026, extending a long streak of quarterly losses.
  • Earnings were negative in every quarter shown from 2024 through Q1 2026, with the company only briefly near profitability in some 2023 quarters.
  • Operating expenses remain high relative to gross profit, and SG&A plus other operating costs continue to pressure margins.
  • Restructuring charges have been persistent, including $9 million in Q1 2026 and $21 million in Q4 2025, suggesting ongoing business adjustments.
  • The balance sheet still carries a large liability load, with total liabilities of $1.759 billion versus $1.509 billion in equity.
  • Short-term obligations are sizable, including $584 million of accounts payable and $367 million of accrued expenses in Q1 2026.
  • Cash generation remains inconsistent quarter to quarter, with operating cash flow swinging from positive in some periods to negative in others.

Bottom line: RXO appears to be stabilizing compared with its weaker 2024 results, especially on operating margin and cash flow, but it is not yet consistently profitable. Investors should focus on whether the company can keep narrowing losses, convert revenue into sustained operating cash flow, and continue reducing balance-sheet risk.

06/15/26 03:02 AM ETAI Generated. May Contain Errors.

RXO Financials - Frequently Asked Questions

According to the most recent income statement we have on file, RXO's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

RXO's net income appears to be on an upward trend, with a most recent value of -$100 million in 2025, falling from $43 million in 2020. The previous period was -$290 million in 2024. Check out RXO's forecast to explore projected trends and price targets.

RXO's total operating income in 2025 was -$79 million, based on the following breakdown:
  • Total Gross Profit: $1.13 billion
  • Total Operating Expenses: $1.21 billion

Over the last 5 years, RXO's total revenue changed from $3.36 billion in 2020 to $5.74 billion in 2025, a change of 71.0%.

RXO's total liabilities were at $1.74 billion at the end of 2025, a 3.7% decrease from 2024, and a 73.9% increase since 2021.

In the past 4 years, RXO's cash and equivalents has ranged from $5 million in 2023 to $98 million in 2022, and is currently $17 million as of their latest financial filing in 2025.

Over the last 5 years, RXO's book value per share changed from 0.00 in 2020 to 9.39 in 2025, a change of 939.0%.


Related Companies

Financial statements for NYSE:RXO last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel